Puma Biotechnology shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q3 sales guidance above estimates. Also, the company raised its FY25 sales guidance above estimates.

2025-11-08 00:15

在該公司報告第三季度財務業績好於預期併發布第三季度銷售指引高於預期后，Puma Biotechnology股價走高。此外，該公司還將25財年的銷售指引提高至高於預期。